Analysis on the clinical effect, adverse events of medical devices and prognosis of microwave hyperthermia combined with radiotherapy in the treatment of patients with advanced gastric cancer
10.3760/cma.j.issn.1008-6706.2020.09.017
- VernacularTitle:微波热疗联合放射治疗晚期胃癌患者临床疗效、预后与医疗器械不良事件分析
- Author:
Mingxiao CHEN
1
;
Kaidong LIU
;
Jidong ZHANG
Author Information
1. 山西省肿瘤医院放疗腹盆二病区，太原 030013
- From:
Chinese Journal of Primary Medicine and Pharmacy
2020;27(9):1106-1110
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the clinical effect, adverse events and prognosis of microwave hyperthermia combined with radiotherapy in the treatment of patients with advanced gastric cancer.Methods:From May 2017 to May 2019, 80 patients with advanced gastric cancer admitted to Cancer Hospital of Shanxi Province were selected and divided into two groups according to the random digital table method, with 40 cases in each group.The control group was treated with radiotherapy, and the study group was treated with microwave hyperthermia on the basis of the control group.The clinical efficacy, adverse events and prognosis of the two groups were compared.Results:The total effective rate in the study group was 90.00%(36/40), which was higher than 70.00%(28/40) in the control group (χ 2=5.000, P<0.05). After treatment, the diameter of tumor in the study group was lower than that in the control group[(2.30±0.20)cm vs.(2.66±0.23)cm, t=7.470, P<0.05]. The incidence of adverse events in the study group was 10.00%(4/40), which was lower than 27.50%(11/40) in the control group(χ 2=4.020, P<0.05). The quality of life scores of the study group[physiological function (74.17±5.23)points, physical pain (73.07±5.49)points, general health (75.13±5.50)points, mental state (75.16±3.27)points and social function (75.49±3.24)points] were better than those of the control group[(62.55±5.70)points, (63.24±6.37)points, (65.72±5.30)points, (63.05±2.49)points, (65.34±4.59)points]( t=9.500, 7.393, 7.791, 18.634, 11.425, all P<0.05). Conclusion:Microwave hyperthermia combined with radiotherapy can reduce adverse events and improve the quality of life of patients with advanced gastric cancer.
